Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

NCT01703702 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

641

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: florbetapir (18F)

Sponsor

Avid Radiopharmaceuticals

Collaborators

[object Object]